Profound Medical Corp
TSX:PRN
Profound Medical Corp
EPS (Diluted)
Profound Medical Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
EPS (Diluted)
-$1
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Titan Medical Inc
TSX:TMD
|
EPS (Diluted)
$0
|
CAGR 3-Years
53%
|
CAGR 5-Years
54%
|
CAGR 10-Years
37%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
|
MedMira Inc
XTSX:MIR
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's EPS (Diluted)?
EPS (Diluted)
-1.1
USD
Based on the financial report for Dec 31, 2024, Profound Medical Corp's EPS (Diluted) amounts to -1.1 USD.
What is Profound Medical Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
4%
Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Profound Medical Corp have been 9% over the past three years , 4% over the past five years .
You don't have any saved screeners yet